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Process development for large-scale ex vivo expansion
of allogeneic natural killer cells in stirred-tank bioreactor
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INTRODUCTION

ADVANCED PARAMETERS CORRELATION (2 L AND 50 L STR)

1. Natural Killer (NK) Cell

Computational Fluid Dynamics (CFD) simulation has become a widely applicable numerical technique for understanding local properties
(e.g., fluid velocity, gas holdup, and shear stress). Navier-Stokes equation is basic for calculating flow dynamics with time, and its derived
modeling relating to turbulence is introduced to predict advanced parameters. Shear strain rate (SSR) and turbulent kinetic energy (TKE)
are the most two well-known parameters to study cell damage in cultivation and mass transfer, respectively.
Applying calculated RPM to operation at 50 L scale, x, y, z-axis velocities (u, v, w) were 1.83, 1.84, 1.18-fold faster than in 2 L scale, respectively
(Fig. 1). Distribution of faster velocity generally causes the shear field to become intense, which can raise the issues in cell damage during
cultivation. CFD results, however, showed the reduction in shear strain rate by 37.4% in scaling up to 50 L (Fig. 2), and turbulent kinetic energy
(TKE) of 50 L bioreactor got more increased by 47.3% along Z-axis than of 2 L bioreactor (Fig. 3). Both macroscopic similarity and infinitesimal
analysis via CFD demonstrated that scale-up to 50 L could lower SSR and enhance TKE with the comparability to 2 L scale bioreactor process,
which could be available to cultivate NK cells.

Natural killer (NK) cells are a type of lymphocytes in the blood that are responsible for innate and adaptive immune response and they
mature in the liver and bone marrow. Being a key role in host defense system with direct and indirect killing of virus-infected cells or
cancer cells, NK cell has been considered an attractive candidate for cancer therapy. Peripheral blood shows the low frequency of NK
cells, so the ex vivo expansion method is important to obtain sufficient NK cells for therapeutic use.

2. Stirred-Tank Reactor (STR)
PROS
•
•
•
•

CONS

High scalability, standardization, and reproducibility • Shear stress to sensitive cells, causing low yield
Easy to monitor and control temperature, pH, dO2, dCO2
Nutrient
Saving on operating (labor) cost and preparing time
Mass Transfer O2 or CO2 Yield, Quality
Closed system- safe, simple and clean
Turbulence
Hydrodynamic
Yield, Quality
Shear Field
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3. Schematic Representation of ex vivo Expansion of NK Cells at Manufacturing Scale
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METHOD
Comparability between Different Scale Bioreactors in ex vivo NK Cell Expansion

𝜀𝐿
𝑘𝐿 = 𝐶1 · 𝐷𝐿 ·
𝜈𝐿

Latin symbols
C1 Constant (for Oxygen Diffusivity)
D Diameter of Stirrer
DL Oxygen Diffusivity (1.98 × 10-9 m2 s-1 in water at 20°C)
kL Oxygen Transfer Coefficient
M Torque
N Rotation Speed
Ne Newton Number
P Power
u Velocity to x-axis
V Volume

a)

2. Computational Fluid
Dynamics (CFD)
• ANSYS Software Student Ver. 19.2
• General Turbulent Model: k-ε Model

0.25

Greek symbols
εL Turbulent Energy Dissipation Rate
μ Dynamic Viscosity
vL Kinematic Viscosity
ρL Density of Liquid Phase
τ Shear Stress

3. In-Process Control (IPC)
& Quality Control (QC)
•
•
•
•
•
•

Viable Cell Density (VCD)
Viability
Concentration of Glucose, Lactate
Potency (Cytotoxicity)
Identity
Purity

It is necessary to provide homogenous culture conditions. So we studied effects of agitation at manufacturing-scale (50 L) and figured
out an optimum condition based on the comparability to the lab-scale (2 L) bioreactor, for which In-Process Control (IPC) and Quality
Control (QC) were carried out in terms of growth rate, viability cytotoxicity, and purity.
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Figure 4. Comparability test for a)
population doubling level (PDL), b) viability,
concentration of c) glucose consumed and
d) lactate produced, e) cytotoxicity against
K562, and f) purity between lab-scale
bioreactor (2 L) (N=8) and manufacturingscale bioreactor (50 L), indicated by red and
blue color, respectively
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• Advanced Parameters
• Classical Parameters
- Shear Stress
- Geometry of Bioreactors
𝛿𝑢
- Power Input (P/V) Work on Mixing
𝜏=𝜇
𝛿𝑦
𝑃 𝑁𝑒 · 𝜌𝐿 · 𝑁3 · 𝐷5
=
- Mass Transfer
𝑉
𝑉

2L
50 L
Figure 3. Turbulent kinetic energy (TKE) at 2 L scale and 50 L scale
(0.82 J kg-1 and 1.20 J kg-1, respectively)
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1. Engineering Parameters for Scale-Up
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Figure 2. Shear strain rate (SSR) at 2 L scale and 50 L scale (5.98 s1 and 3.74 s-1 respectively)
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4. Aim : Manufacturing Scale-Up with Comparability to Lab Scale Bioreactor

Lab-scale
Bioreactor
(2 L)

Z (m)

Figure 1. Comparison of velocity distribution on coordinate frame (x-, y-, z-axis) at lab-scale (2 L) and manufacturing-scale (50 L).
Contour graphs on xz-plane (left) and scatter graphs (right) on z-axis represented a) u velocity (x-direction) at 2 L scale and 50 L scale
(ave. 0.011 m s-1 and ave. 0.020 m s-1, respectively), b) v velocity (y-direction) at 2 L scale and 50 L scale (ave. 0.011 m s-1 and ave. 0.020
m s-1, respectively), and c) w velocity (z-direction) at 2 L scale and 50 L scale (ave. 0.029 m s-1 and ave. 0.034 m s-1, respectively)

Stirred-tank bioreactor could be considered as an optimal alternative system for large-scale NK cell expansion compared with other
ones because it is automated, less labor-intensive, scalable, well-controlled and cost-effective. We firstly developed a lab-scale
bioreactor process for ex vivo expansion of NK cell in the world. With the need for reduction in production cost and easy-to-control
large-scale production, we advanced the lab-scale bioreactor process to manufacturing scale by 50 L.
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Population doubling level (PDL), viability, the cumulative concentration of glucose consumed and lactate produced were measured with time. All
the IPC data at 50-L scale showed to be comparable with 2 L scale. Harvested NK cells from 50 L bioreactor were analyzed for cytotoxicity and purity.
It was confirmed that manufacturing scale cultivation was also comparable with its cytotoxicity against K562 cells and purity.

CONCLUSION
Bioreactor process at 50 L scale was demonstrated to be comparable as at 2 L scale in producing allogeneic NK cells. Scale-up parameters were
optimized with classical engineering parameters and advanced engineering parameters. The similarity of classical parameters (power input
(P/V), Newton number (Ne), geometry) helped to calculate which RPM could be operated at 50 L scale. In addition to that, Infinitesimal
analysis based on advanced parameters, showed that 50 L scale operation with the RPM lowered shear stress but increased turbulent kinetic
energy. Under the circumstance, PDL (~12), viability (>95%), cytotoxicity, and purity (>99% of CD3-CD56+) of cells at 50 L scale were almost
comparable with ones at 2 L scale. The developed process will be applied to produce clinical materials for phase III.

CLASSICAL PARAMETERS CORRELATION (2 L AND 50 L STR) REFERENCES
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